• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR).

作者信息

Wang Tracy Y, Peterson Eric D, Dai David, Anderson H Vernon, Rao Sunil V, Brindis Ralph G, Roe Matthew T

出版信息

J Am Coll Cardiol. 2008 May 27;51(21):2068-74. doi: 10.1016/j.jacc.2008.01.054.

DOI:10.1016/j.jacc.2008.01.054
PMID:18498965
Abstract
摘要

相似文献

1
Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR).
J Am Coll Cardiol. 2008 May 27;51(21):2068-74. doi: 10.1016/j.jacc.2008.01.054.
2
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes.2005年经皮冠状动脉介入治疗后肌酸激酶同工酶升高是否能预测预后？围手术期心肌酶升高可预测不良预后。
Circulation. 2005 Aug 9;112(6):906-15; discussion 923. doi: 10.1161/CIRCULATIONAHA.104.483297.
3
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes.
Circulation. 2005 Aug 9;112(6):916-22; discussion 922.
4
Comparing hospital performance in door-to-balloon time between the Hospital Quality Alliance and the National Cardiovascular Data Registry.比较医院质量联盟与国家心血管数据登记处之间在门球时间方面的医院表现。
J Am Coll Cardiol. 2007 Oct 9;50(15):1517-9. doi: 10.1016/j.jacc.2007.07.010. Epub 2007 Sep 24.
5
Diagnostic criteria for percutaneous coronary intervention-related myocardial infarction: time for revision?
J Am Coll Cardiol. 2011 Jul 12;58(3):312-3; author reply 313. doi: 10.1016/j.jacc.2011.02.058.
6
Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.急性心肌梗死患者直接经皮冠状动脉介入治疗后，入院时肾小球滤过率对心肌灌注不良发生的影响。
Coron Artery Dis. 2008 Dec;19(8):543-9. doi: 10.1097/MCA.0b013e3283108fef.
7
Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
Eur Heart J. 2005 Oct;26(20):2206; author reply 2206-7. doi: 10.1093/eurheartj/ehi424. Epub 2005 Aug 8.
8
Cardiac biomarker measurement after elective percutaneous coronary interventions in older patients: insights from the National Cardiovascular Data Registry.择期经皮冠状动脉介入治疗后老年患者的心脏生物标志物测量：来自全国心血管数据注册中心的见解。
Am Heart J. 2013 Nov;166(5):927-34. doi: 10.1016/j.ahj.2013.09.007. Epub 2013 Oct 4.
9
Myocardial damage in successful single vessel coronary angioplasty as assessed by creatinine kinase and its myocardium band isoenzyme levels.通过肌酸激酶及其心肌带同工酶水平评估成功的单支冠状动脉血管成形术中的心肌损伤。
J Coll Physicians Surg Pak. 2008 Mar;18(3):142-6.
10
Myocardial protection with a beta blocker and glycoprotein IIb/IIIa inhibitor during PCI: attractive concept, but limited evidence of benefit.
Catheter Cardiovasc Interv. 2008 Oct 1;72(4):498-9. doi: 10.1002/ccd.21784.

引用本文的文献

1
Periprocedural Myocardial Infarction following Elective Percutaneous Coronary Interventions.择期经皮冠状动脉介入治疗后的围手术期心肌梗死
Rev Cardiovasc Med. 2022 Sep 13;23(9):309. doi: 10.31083/j.rcm2309309. eCollection 2022 Sep.
2
Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.在人体经皮冠状动脉和外周动脉介入期间，生物活性氧化磷脂和氧化胆固醇酯的释放和捕获。
J Am Coll Cardiol. 2014 May 20;63(19):1961-71. doi: 10.1016/j.jacc.2014.01.055. Epub 2014 Mar 5.
3
Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study.
慢性完全闭塞性经皮介入治疗中的围手术期心肌损伤：一项系统性心脏生物标志物评估研究
JACC Cardiovasc Interv. 2014 Jan;7(1):47-54. doi: 10.1016/j.jcin.2013.07.011. Epub 2013 Dec 11.
4
Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).考虑对冠状动脉血运重建后临床相关心肌梗死的新定义：心血管血管造影和介入学会（SCAI）的专家共识文件。
J Am Coll Cardiol. 2013 Oct 22;62(17):1563-70. doi: 10.1016/j.jacc.2013.08.720.
5
Incidence of periprocedural myocardial infarction and cardiac biomarker testing after percutaneous coronary intervention in Japan: results from a multicenter registry.日本经皮冠状动脉介入治疗后围手术期心肌梗死的发生率及心脏生物标志物检测：一项多中心注册研究的结果
Heart Vessels. 2013 Nov;28(6):714-9. doi: 10.1007/s00380-012-0314-x. Epub 2012 Dec 29.
6
Periprocedural myocardial enzyme elevation: prognostic implications for current practice.围术期心肌酶升高：当前实践的预后意义。
Curr Cardiol Rep. 2012 Aug;14(4):424-32. doi: 10.1007/s11886-012-0288-4.
7
Changing nature of cardiac interventions in older adults.老年人心脏介入治疗性质的变化。
Aging health. 2011 Apr;7(2):283-295. doi: 10.2217/ahe.11.12.